Antiemetic medications for adults
Pro Research Analysisby 
Searched over 200M research papers
Common Antiemetic Medications for Adults: Emergency, Postoperative, and Chemotherapy Settings
Antiemetic Medications in the Emergency Department
In adult emergency department (ED) patients, commonly used antiemetic medications include ondansetron, metoclopramide, prochlorperazine, promethazine, and droperidol. Studies show that ondansetron and metoclopramide provide similar reductions in nausea severity compared to placebo, with no significant differences in patient satisfaction or need for rescue medication. Most patients, regardless of treatment, report improvement, suggesting that supportive care alone may be sufficient for many cases. Adverse events are generally mild, and no single drug has shown clear superiority over others or over placebo in this setting. The choice of antiemetic may depend on side effect profiles, patient preference, and cost considerations Egerton-Warburton2014Patanwala2010Furyk2015.
Prophylactic Antiemetics with Opioid Use
For adults receiving intravenous opioids in acute care, prophylactic use of metoclopramide does not significantly reduce the risk of nausea, vomiting, or the need for rescue antiemetic medication compared to placebo. The reduction in nausea severity is minimal and not clinically significant. The evidence supporting routine prophylactic antiemetic use in this context is low certainty, and further research is needed .
Antiemetic Medications for Postoperative Nausea and Vomiting (PONV)
For prevention of postoperative nausea and vomiting after general anesthesia, several antiemetic drugs are effective. High-certainty evidence supports the use of aprepitant, ramosetron, granisetron, dexamethasone, and ondansetron, all of which significantly reduce vomiting compared to placebo. Drug combinations are generally more effective than single agents. Droperidol is also effective but is used less frequently due to concerns about QT prolongation. Olanzapine, when used as a prophylactic antiemetic, can reduce the incidence of PONV by up to 49% at a 10 mg dose, though more research is needed to fully assess its safety profile Weibel2017Weibel2021Grigio2025.
Antiemetic Regimens for Chemotherapy-Induced Nausea and Vomiting (CINV)
For adults undergoing moderately or highly emetogenic chemotherapy, the most effective antiemetic regimens combine a 5-HT₃ receptor antagonist (such as ondansetron, granisetron, or palonosetron), a corticosteroid (such as dexamethasone), and a neurokinin-1 (NK₁) receptor antagonist (such as aprepitant, fosaprepitant, or netupitant). Adding olanzapine to these regimens can further reduce the likelihood of nausea, especially in high-risk patients. These combination therapies are recommended by major guidelines and have been shown to provide superior control of both acute and delayed phases of CINV compared to regimens without NK₁ antagonists or olanzapine Piechotta2021Link2021Hesketh2017.
Safety and Side Effects
Most antiemetic medications are well tolerated, with adverse events generally being mild. Ondansetron is not associated with sedation or akathisia, while promethazine is more sedating and droperidol carries a risk of QT prolongation. Monitoring for side effects such as headache, constipation, and extrapyramidal symptoms is recommended, especially with dopamine antagonists like metoclopramide and prochlorperazine Patanwala2010Weibel2017.
Conclusion
For adults, the choice of antiemetic medication depends on the clinical context—emergency, postoperative, or chemotherapy-induced nausea and vomiting. While many antiemetics are similarly effective in the ED, combination regimens are preferred for chemotherapy and postoperative settings. Safety profiles, patient preferences, and specific clinical scenarios should guide the selection of antiemetic therapy.
Sources and full results
Most relevant research papers on this topic